# APTENSIO XR

NDC: 42858-403
Generic name: methylphenidate hydrochloride
Labeler / Manufacturer: Rhodes Pharmaceuticals L.P.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20150417

FDA application: NDA205831

## Active ingredients

- METHYLPHENIDATE HYDROCHLORIDE: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42858-403"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42858-403
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5adedc01-ebf0-11e3-ac10-0800200c9a66